Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Archives of Psychiatry and Clinical Neuroscience
Metadata
Title
Neurotransmitter interactions in schizophrenia-therapeutic implications
Authors
A. Carlsson
Nicholas Waters
Maria L. Carlsson
Publication date
01-12-1999
Publisher
Steinkopff Verlag
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue Special Issue 4/1999
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/PL00014183

Other articles of this Special Issue 4/1999

European Archives of Psychiatry and Clinical Neuroscience 4/1999 Go to the issue

OriginalPaper

The neuropathology of schizophrenic diseases: historical aspects and present knowledge

OriginalPaper

Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

OriginalPaper

Atypical neuroleptics: a new approach in the treatment of negative symptoms

OriginalPaper

Structural neuroimaging in schizophrenia

OriginalPaper

Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia

OriginalPaper

Principles and results of family therapy in schizophrenia